3.10Open3.10Pre Close0 Volume10 Open Interest2.50Strike Price0.00Turnover0.00%IV3.90%PremiumOct 18, 2024Expiry Date2.89Intrinsic Value100Multiplier17DDays to Expiry0.21Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.91Leverage Ratio--Theta--Rho--Eff Leverage--Vega
INmune Bio Stock Discussion
• $SpringWorks Therapeutics (SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences (ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen (OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Champion Homes (SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase (NTES.US)$ +4.1% (In...
No comment yet